• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生成一种针对结核分枝杆菌(Mtb)热休克蛋白(HSP)16kDa 抗原的 T 细胞受体(TCR)样单域抗体(sDAb),该抗原由人类白细胞抗原(HLA)-A*02 呈递。

Generation of a T cell receptor (TCR)-like single domain antibody (sDAb) against a Mycobacterium Tuberculosis (Mtb) heat shock protein (HSP) 16kDa antigen presented by Human Leukocyte Antigen (HLA)-A*02.

机构信息

Institute for Research in Molecular Medicine, Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia.

School of Health Sciences, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia.

出版信息

Mol Immunol. 2018 Sep;101:189-196. doi: 10.1016/j.molimm.2018.07.001. Epub 2018 Jul 4.

DOI:10.1016/j.molimm.2018.07.001
PMID:30007228
Abstract

The discovery of heat shock protein 16 kDa antigen protein has deepen the understanding of latent tuberculosis since it was found to be primarily expressed by Mycobacterium tuberculosis during latent phase leading to the rapid optimization and development in terms of diagnosis and therapeutics. Recently, T cell receptor-like antibody has been explored extensively targeting various diseases due to its dual functionality (T cell receptor and antibody). In this study, a TCR-like domain antibody (A2/Ab) with the binding capacity to Mtb heat shock protein (HSP) 16 kDa antigen presented by major histocompatible complex (MHC) HLA-A*02 was successfully generated via biopanning against human domain antibody library. The generated antibody (A2/Ab) exhibited strong functionality and binding capacity against the target assuring the findings of this study to be beneficial for the development of latent tuberculosis diagnosis and immunotherapeutics in future.

摘要

热休克蛋白 16kDa 抗原蛋白的发现加深了对潜伏性结核的认识,因为它主要在潜伏期的结核分枝杆菌中表达,从而导致诊断和治疗方面的快速优化和发展。最近,由于 T 细胞受体样抗体具有双重功能(T 细胞受体和抗体),因此针对各种疾病进行了广泛的探索。在这项研究中,通过对人源抗体文库进行生物淘选,成功地产生了与主要组织相容性复合体 (MHC) HLA-A*02 呈递的结核分枝杆菌热休克蛋白 (HSP) 16kDa 抗原结合的 TCR 样结构域抗体 (A2/Ab)。生成的抗体 (A2/Ab) 对靶标表现出强大的功能和结合能力,确保了本研究的结果有利于未来潜伏性结核病诊断和免疫治疗的发展。

相似文献

1
Generation of a T cell receptor (TCR)-like single domain antibody (sDAb) against a Mycobacterium Tuberculosis (Mtb) heat shock protein (HSP) 16kDa antigen presented by Human Leukocyte Antigen (HLA)-A*02.生成一种针对结核分枝杆菌(Mtb)热休克蛋白(HSP)16kDa 抗原的 T 细胞受体(TCR)样单域抗体(sDAb),该抗原由人类白细胞抗原(HLA)-A*02 呈递。
Mol Immunol. 2018 Sep;101:189-196. doi: 10.1016/j.molimm.2018.07.001. Epub 2018 Jul 4.
2
TCR-like domain antibody against Mycobacterium tuberculosis (Mtb) heat shock protein antigen presented by HLA-A*11 and HLA-A*24.针对结核分枝杆菌(Mtb)热休克蛋白抗原呈递的 HLA-A*11 和 HLA-A*24 的 TCR 样结构域抗体。
Int J Biol Macromol. 2020 Jul 15;155:305-314. doi: 10.1016/j.ijbiomac.2020.03.229. Epub 2020 Mar 30.
3
Investigating the Diagnostic and Therapeutic Potential of a T Cell Receptor (TCR)-like single Domain Antibody (sDAb)-Human IgG1 Antibody against Heat Shock Protein (HSP) 16KDa/HLA-A2 for Latent Tuberculosis.研究一种针对热休克蛋白(HSP)16KDa/HLA-A2的T细胞受体(TCR)样单域抗体(sDAb)-人IgG1抗体对潜伏性结核的诊断和治疗潜力。
Trop Med Infect Dis. 2024 Jun 26;9(7):139. doi: 10.3390/tropicalmed9070139.
4
Identification of HLA-A24-binding peptides of Mycobacterium tuberculosis derived proteins with beta 2m linked HLA-A24 single chain expressing cells.鉴定与β2m 连接 HLA-A24 单链表达细胞的结核分枝杆菌衍生蛋白的 HLA-A24 结合肽。
Immunol Invest. 2010 Jan;39(2):103-13. doi: 10.3109/08820130903496777.
5
T lymphocytes from healthy individuals with specificity to self-epitopes shared by the mycobacterial and human 65-kilodalton heat shock protein.来自健康个体的T淋巴细胞,对分枝杆菌和人类65千道尔顿热休克蛋白共有的自身表位具有特异性。
J Immunol. 1989 Nov 1;143(9):2844-9.
6
Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis.结核分枝杆菌热休克蛋白与结节病的自身免疫。
Autoimmun Rev. 2010 Apr;9(6):419-24. doi: 10.1016/j.autrev.2009.11.015. Epub 2009 Nov 27.
7
Development of genetically engineered iNKT cells expressing TCRs specific for the M. tuberculosis 38-kDa antigen.表达针对结核分枝杆菌38 kDa抗原的TCR的基因工程iNKT细胞的开发。
J Transl Med. 2015 May 7;13:141. doi: 10.1186/s12967-015-0502-4.
8
Limited restriction in the TCR-alpha beta V region usage of antigen-specific clones. Recognition of myelin basic protein (amino acids 84-102) and Mycobacterium bovis 65-kDa heat shock protein (amino acids 3-13) by T cell clones established from peripheral blood mononuclear cells of monozygotic twins and HLA-identical individuals.抗原特异性克隆在TCR-αβ V区使用上的限制有限。从同卵双胞胎和HLA相同个体的外周血单个核细胞建立的T细胞克隆对髓鞘碱性蛋白(氨基酸84 - 102)和牛分枝杆菌65-kDa热休克蛋白(氨基酸3 - 13)的识别。
J Immunol. 1995 Jan 15;154(2):555-66.
9
Is mycobacterial heat shock protein 16 kDa, a marker of the dormant stage of Mycobacterium tuberculosis, a sarcoid antigen?分支杆菌热休克蛋白 16 kDa 是否为结核分枝杆菌休眠期的标志物,也是肉样瘤病的抗原?
Hum Immunol. 2013 Jan;74(1):45-51. doi: 10.1016/j.humimm.2012.10.007. Epub 2012 Oct 16.
10
MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis.MHC II类四聚体引导检测肺结核患者外周血中结核分枝杆菌特异性CD4+ T细胞
Scand J Immunol. 2007 May;65(5):467-78. doi: 10.1111/j.1365-3083.2007.01924.x.

引用本文的文献

1
Development of an innovative approach for early diagnosis of cervical cancer using TCR‑like antibodies targeting HPV18 E6 and E7 peptides.利用靶向人乳头瘤病毒18型E6和E7肽的类T细胞受体抗体开发宫颈癌早期诊断的创新方法。
Mol Med Rep. 2025 Aug;32(2). doi: 10.3892/mmr.2025.13583. Epub 2025 Jun 6.
2
Investigating the Diagnostic and Therapeutic Potential of a T Cell Receptor (TCR)-like single Domain Antibody (sDAb)-Human IgG1 Antibody against Heat Shock Protein (HSP) 16KDa/HLA-A2 for Latent Tuberculosis.研究一种针对热休克蛋白(HSP)16KDa/HLA-A2的T细胞受体(TCR)样单域抗体(sDAb)-人IgG1抗体对潜伏性结核的诊断和治疗潜力。
Trop Med Infect Dis. 2024 Jun 26;9(7):139. doi: 10.3390/tropicalmed9070139.
3
The Future of TCR-like Antibodies in Diagnosis and Potential Application Targets.
TCR 样抗体在诊断中的未来及潜在应用靶点
Curr Mol Med. 2025;25(6):672-685. doi: 10.2174/0115665240297179240514030532.
4
Identification of immune-related genes and patient selection for hepatocellular carcinoma immunotherapy.肝细胞癌免疫治疗免疫相关基因的鉴定及患者选择
Transl Cancer Res. 2023 May 31;12(5):1210-1231. doi: 10.21037/tcr-22-2304. Epub 2023 Apr 13.
5
Role of antibodies in vaccine-mediated protection against tuberculosis.抗体在疫苗介导的抗结核保护中的作用。
Cell Mol Immunol. 2022 Jul;19(7):758-760. doi: 10.1038/s41423-022-00861-6. Epub 2022 Apr 8.
6
The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic.新型冠状病毒肺炎/结核病综合征及从大流行中吸取的经验教训对结核病抗体治疗的启示
Front Immunol. 2022 Feb 15;13:833715. doi: 10.3389/fimmu.2022.833715. eCollection 2022.
7
The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy.T 细胞受体(TCR)样抗体在宫颈癌免疫治疗中的潜在应用。
Hum Vaccin Immunother. 2021 Sep 2;17(9):2981-2994. doi: 10.1080/21645515.2021.1913960. Epub 2021 May 14.
8
A Direct Role for the CD1b Endogenous Spacer in the Recognition of a Antigen by T-Cell Receptors.CD1b 内源性间隔区在 T 细胞受体识别 抗原中的直接作用。
Front Immunol. 2020 Oct 14;11:566710. doi: 10.3389/fimmu.2020.566710. eCollection 2020.
9
Selection of a Single Domain Antibody, Specific for an HLA-Bound Epitope of the Mycobacterial Ag85B Antigen.针对分枝杆菌 Ag85B 抗原 HLA 结合表位的单域抗体的选择。
Front Immunol. 2020 Oct 2;11:577815. doi: 10.3389/fimmu.2020.577815. eCollection 2020.
10
Targeting the MHC Ligandome by Use of TCR-Like Antibodies.利用类TCR抗体靶向主要组织相容性复合体配体组
Antibodies (Basel). 2019 May 9;8(2):32. doi: 10.3390/antib8020032.